ArticleMolecular cancer therapeutics2009

Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.

Sarah E Golding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.